Advanced SearchNewsfeedFollowed Companies

Eli Lilly's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Eli Lilly develops, produces and markets pharmaceutical products for health care professionals, patients and consumers.

E... Read more

Based on data from Eli Lilly's latest SEC filings

Annual Revenue

Based on data from Eli Lilly's latest SEC filings

Employees

David A. Ricks's photo - Chairman & CEO of Eli Lilly

Chairman & CEO

David A. Ricks

CEO Approval Rating

73/100

OVERVIEW

Founded:

1876

Headquarters:

IndianapolisIndiana

Status:

PublicNYSELLY

Industry Sector:

Pharmaceuticals

SIC Code:

2834NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Baxter a competitor of Eli Lilly?

I don't know

Trending News for Eli Lilly and Eli Lilly's Competitors

February 15, 2020

MarketScreener

Bristol Myers Squibb : Updated CheckMate -025 Results Show 26% of Patients Treated with Opdivo are Alive at Five Years in Patients with Previously Treated Advanced or Metastatic Renal Cell Carcinoma

(marketscreener.com) Bristol-Myers Squibb Company today announced five-year follow-up results from th... See more »

February 14, 2020

The Business Journals: Minneapolis/St. Paul

Medtronic buys British surgical AI company called Digital Surgery

Medtronic (NYSE: MDT) has acquired Digital Surgery, a British health-tech company, for an undisclosed... See more »

February 14, 2020

MarketScreener

GlaxoSmithKline : Description Amended Statement of Beneficial Ownership

(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

AbbVie is one of Eli Lilly's top rivals. AbbVie is a Public company that was founded in 2013 in North Chicago, Illinois. Like Eli Lilly, AbbVie also works within the Pharmaceuticals industry. Compared to Eli Lilly, AbbVie has 8,680 fewer employees.

Amgen is seen as one of Eli Lilly's biggest rivals. Amgen was founded in 1980 in Thousand Oaks, California. Amgen competes in the Biotechnology industry. Amgen generates $1.5B less revenue than Eli Lilly.

AstraZeneca is one of Eli Lilly's top competitors. AstraZeneca was founded in 1999, and its headquarters is in Cambridge, England. Like Eli Lilly, AstraZeneca also operates in the Pharmaceuticals sector. AstraZeneca has 25,920 more employees than Eli Lilly.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

David A. Ricks

Chairman & CEO

- -
38,680
$0
$24.9B
1

Richard A. Gonzalez

Chairman & CEO

87/100
78
$3.8B
$32.9B
2

Robert A. Bradway

Chairman & CEO

72/100
19,200
$19M
$1.2B
3

Pascal Soriot

CEO

72/100
59,700
- -
$24.1B
4

Jose E Almeida

Chairman & CEO

76/100
50,000
- -
$11.1B
5

Michel Vounatsos

CEO

69/100
7,800
- -
$50B
6

Giovanni Caforio

Chairman & CEO

65/100
23,300
- -
$24.2B
7

Mark J. Alles

Chairman & CEO

76/100
8,852
- -
$17B
8

Daniel O’Day

Chairman & CEO

71/100
11,000
$86.3M
$22.4B
9

Emma Walmsley

CEO

70/100
99,827
- -
$40.4B
10

Alex Gorsky

Chairman & CEO

71/100
135,100
- -
$81.7B
The top 10 competitors in Eli Lilly's competitive set are AbbVie, Amgen, AstraZeneca, Baxter, Biogen, Bristol Myers Squibb, Celgene, Gilead, GSK and Johnson & Johnson. Together they have raised over 3.9B between their estimated 446.7K employees. Eli Lilly has 38,680 employees and is ranked 5th among it's top 10 competitors. The top 10 competitors average 41,230.

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$24.9B

Eli Lilly's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 30B. Over the last four quarters, Eli Lilly's revenue has decreased by 37.1%. Specifically, in Q3 2019's revenue was $5.5B; in Q2 2019, it was $5.6B; in Q1 2019, it was $5.1B; in Q4 2018, Eli Lilly's revenue was $8.7B.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Dermira, Inc.

Jan 2020

Source »
$1.1B
Dermira develops and commercializes therapeutics for the treatment of dermatological diseases.
Loxo Oncology, Inc.

Jan 2019

Source »
$8B
Loxo Oncology develops and markets genomic medicines for the treatment of cancer.
ARMO BioSciences, Inc.

May 2018

Source »
$1.6B
ARMO BioSciences develops immunotherapies for the treatment of cancer, fibrosis, hypercholesterolemia and inflammatory diseases.
Colucid Pharmaceuticals, Inc.

Jan 2017

Source »
$960M
Colucid is focused on developing drug for the acute treatment of migraine headaches and CNS disorders.
Boehringer Ingelheim Vetmedica, Inc.

Oct 2016

Source »
undisclosed
Boehringer Ingelheim is a pharmaceutical firm that discovers and develops drugs for animals.

These are all the companies that Eli Lilly has acquired. Eli Lilly has acquired 8 companies and its latest acquisition was Dermira, Inc. in Jan 2020. Dermira develops and commercializes therapeutics for the treatment of dermatological diseases.

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

DTx Pharma develops and commercializes novel RNA therapeutics for the treatment of rare diseases.
$10.6M
Jan 05, 2020
Series A
-
Avidity Biosciences develops and markets oligonucleotide-based therapeutics to treat muscle disorders.
$100M
Nov 12, 2019
Series C
-
Mission Bay Capital is a venture capital firm specializing in seed and early-stage investments.
$60M
Sep 15, 2019
Investment Fund
-
NextCure is a biopharmaceutical company that researches and develops immuno-medicines for the treatment of cancer.
$93.4M
Nov 12, 2018
Series B
-
Dicerna is a developer of investigational ribonucleic acid interference therapeutics for liver, cardiovascular and viral infectious diseases.
$100M
Oct 28, 2018
Equity
Jan 29, 2014

These are all the companies that Eli Lilly has invested in. Eli Lilly has invested 8 companies and its latest investment was Dermira, Inc. in Jan 2020. Dermira develops and commercializes therapeutics for the treatment of dermatological diseases.

Eli Lilly News

February 13, 2020Medical Buyer

Lilly And Novo Nordisk Question FDA's Draft Guidance On Insulin Biosimilars

In November 2019, the U.S. Food and Drug Administration (FDA) released new draft guidance that would ... See more »
February 12, 2020FinanzNachrichten

Lilly's Study Meets Primary Endpoint Of 75% Improvement Of Skin Inflammation

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. and Incyte said that a Phase 3 Study of Oral Selective JAK... See more »
February 11, 2020Zacks

Lilly Reports Disappointing Data on Alzheimer's Candidate

Eli Lilly's (LLY) Alzheimer's disease drug, solanezumab, fails to meet primary endpoint in a phase II... See more »
February 11, 2020Seeking Alpha

Lilly's Taltz OK'd in Canada for arthritis of the spine

See more »
February 11, 2020The Pharma Letter

The rationale behind Lilly's $1.1 billion takeover of Dermira

A look at why US drugmaker Eli Lilly is willing to spend more than $1 billion on the takeover of derm... See more »
February 10, 2020Reuters

UPDATE 2-Roche, Lilly drugs fail to halt gene-driven Alzheimer's disease

* 100s of Alzheimer's drug trials have failed (Recasts story to add details of Eli Lilly test failure... See more »
February 10, 2020The Pharma Letter

Lilly shares suffer on fresh solanezumab flop

Eli Lilly's hopes that coming up with a new trial design might mean a different result for its Alzhei... See more »

Eli Lilly Blogs

April 30, 2015LILLY BLOG

Polio and the Power of Partnership

See more »
April 29, 2015LILLY BLOG

Producing Innovation: What Does It Take?

See more »
April 28, 2015LILLY BLOG

Why IP and Data Confidentiality Need Protection

See more »
April 28, 2015LILLY BLOG

Embracing the Power of Diversity

See more »
April 25, 2015LILLY BLOG

A Recipe For A Healthier Tomorrow

See more »
April 22, 2015LILLY BLOG

Keep Calm and Recycle On

See more »
April 21, 2015LILLY BLOG

Minority Health: 30 Years After Heckler

See more »

Eli Lilly Press Releases

December 2, 2019PR Newswire

Lilly to Participate in Evercore ISI 2nd Annual HealthCONx Conference

INDIANAPOLIS, Dec. 2, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the ... See more »
November 8, 2019StreetInsider

Lilly Reinforces its Commitment to Rheumatology through Data Showcased at the ACR/ARP Annual Meeting

INDIANAPOLIS, Nov. 8, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that i... See more »
November 6, 2019PR Newswire

Eli Lilly and Company to Present Multiple Abstracts for LOXO-305 at ASH 2019

INDIANAPOLIS, Nov. 6, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that mul... See more »
November 4, 2019PR Newswire

Lilly to Participate in Credit Suisse 28th Annual Healthcare Conference

INDIANAPOLIS, Nov. 4, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the C... See more »
September 30, 2019centralcharts

Adocia Announces Receipt of USD 14.3 million Payment from Eli Lilly Following Arbitration Conclusion and the Decision by Mutual Consent with Eli Lilly to Conclude the Civil Case

Regulatory News: Adocia (Paris:ADOC) (Euronext Paris: FR0011184241 - ADOC), a clinical stage biopharm... See more »
September 20, 2019Korea Newswire

Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced results of a post-hoc anal... See more »
September 11, 2019StreetInsider

Unimpeded by Allergan's Botox Dominance, Amgen/Novartis' Aimovig, Teva's Ajovy, and Eli Lilly's Emgality Use at the Patient Level is More Robust Within the Episodic Migraine Segment Than Physicians Ar

EXTON, Pa., Sept. 11, 2019 /PRNewswire/ -- Contributing physicians appear to underestimate their use ... See more »

Eli Lilly Videos

November 20, 2019Eli Lilly Youtube Channel

"Next Generation Manufacturing at Lilly" on YOUTUBE

See more »
November 15, 2019Eli Lilly Youtube Channel

"Immuno-Oncology Research and the Importance of Saying Yes" on YOUTUBE

See more »
October 25, 2019Eli Lilly Youtube Channel

"#RespectMigraine: International Forum on Women's Brain and Mental Health" on YOUTUBE

See more »
October 23, 2019Eli Lilly Youtube Channel

"Jenny's Journey: Living With Metastatic Breast Cancer" on YOUTUBE

See more »
October 15, 2019Eli Lilly Youtube Channel

"Lilly Global Day of Service: Healthy Lives, Minds & Communities" on YOUTUBE

See more »
October 10, 2019Eli Lilly Youtube Channel

"Caroline's Story - Ankylosing Spondylitis" on YOUTUBE

See more »
October 2, 2019Eli Lilly Youtube Channel

"Lilly's Commitment to Continuous Manufacturing" on YOUTUBE

See more »

Social Statistics

Headquarters

Lilly Corporate Center

Indianapolis, Indiana46285

317-276-2000

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Eli Lilly and Company (NYSE: LLY) manufactures and sells pharmaceutical products for health care professionals, patients, and consumers. Is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana. The company also ...

CEO

Eli Lilly's Chairman & CEO, David A. Ricks, currently has an approval rating of 73%. Eli Lilly's primary competitors are AbbVie, Amgen & AstraZeneca.

Website

lilly.com

Frequently Asked Questions about Eli Lilly

  1. When was Eli Lilly founded?

    Eli Lilly was founded in 1876

  2. Who is Eli Lilly's CEO?

    Eli Lilly's CEO is David A. Ricks

  3. How much revenue does Eli Lilly generate?

    Eli Lilly generates $24.9B in revenue

  4. How much funding does Eli Lilly have?

    Eli Lilly has historically raised $0 in funding

  5. Where is Eli Lilly's headquarters?

    Eli Lilly's headquarters is in Indianapolis Indiana, USA

  1. How many employees does Eli Lilly have?

    Eli Lilly has 38,680 employees

  2. What sector does Eli Lilly operate in?

    Eli Lilly is in Pharmaceuticals

  3. Who are Eli Lilly's competitors?

    Eli Lilly's top competitors are AbbVie, Amgen, AstraZeneca

  4. Who has Eli Lilly invested in?

    Eli Lilly's has invested in companies such as DTX Pharma, Avidity Biosciences, Mission Bay Capital
Stay up-to-date with the latest news on Eli Lilly